Celldex Therapeutics, Inc.
CLDX- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000744218
No open-market purchases or sales by Celldex Therapeutics, Inc. insiders were filed in the last 90 days; 253 institutions reported holding it in 13F filings for Q2 2026, worth $3.16B in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Celldex Therapeutics, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 158 | 160 | +2 |
| Shares | 48.0M | 49.0M | +1.09M (+2.3%) |
| Value | $1.30B | $1.39B | +$86.3M (+6.6%) |
New holders (26)
Institutions that held Celldex Therapeutics, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
Sold out (24)
Institutions that held Celldex Therapeutics, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Viking Global Investors LPSuperinvestorViking Global Investors | 2,337,854 | $63.0M |
| Adage Capital Partners GP, L.L.C. | 400,000 | $10.8M |
| Cormorant Asset Management, LP | 200,000 | $5.39M |
| BVF Inc | 154,000 | $4.15M |
| Millennium Management LLC | 143,343 | $3.87M |
| OrbiMed Advisors LLC | 112,700 | $3.04M |
| Polar Asset Management Partners Inc. | 98,600 | $2.66M |
| Norges Bank | 92,900 | $2.50M |
| Opaleye Management Inc. | 90,000 | $2.43M |
| Squarepoint Ops LLC | 78,345 | $2.11M |
| Woodline Partners LP | 64,454 | $1.74M |
| Jefferies Group LLC | 59,098 | $1.59M |
| Sofinnova Investments, Inc. | 48,304 | $1.30M |
| DLD Asset Management, LP | 36,000 | $971.0K |
| Altshuler Shaham Ltd | 32,000 | $863.0K |
| Winton Group Ltd | 8,322 | $224.0K |
| Janus Henderson Group PLC | 8,062 | $217.0K |
| Campbell & CO Investment Adviser LLC | 8,052 | $217.0K |
| Captrust Financial Advisors | 618 | $17.0K |
| State of Wyoming | 214 | $6.00K |
| Quadrant Capital Group LLC | 132 | $4.00K |
| Meeder Asset Management Inc | 33 | $1.00K |
| Venture Visionary Partners LLC | 10 | $269 |
| CoreCap Advisors, LLC | 16 | $0 |